Cargando…
Isoniazid-induced Immune Thrombocytopenia
Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666230/ https://www.ncbi.nlm.nih.gov/pubmed/34053983 http://dx.doi.org/10.2169/internalmedicine.6520-20 |
_version_ | 1784614162583781376 |
---|---|
author | Kuwabara, Gaku Tazoe, Kumiyo Imoto, Waki Yamairi, Kazushi Shibata, Wataru Oshima, Kazuhiro Yamada, Koichi Takagi, Yasuhiro Shiraishi, Satoshi Hino, Masayuki Kawaguchi, Tomoya Kakeya, Hiroshi |
author_facet | Kuwabara, Gaku Tazoe, Kumiyo Imoto, Waki Yamairi, Kazushi Shibata, Wataru Oshima, Kazuhiro Yamada, Koichi Takagi, Yasuhiro Shiraishi, Satoshi Hino, Masayuki Kawaguchi, Tomoya Kakeya, Hiroshi |
author_sort | Kuwabara, Gaku |
collection | PubMed |
description | Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who developed thrombocytopenia during tuberculosis treatment. Platelet-associated immunoglobulin G and a drug-induced lymphocyte stimulation test for isoniazid were positive; no other causes of thrombocytopenia were identified. The patient was diagnosed with isoniazid-induced immune thrombocytopenia, and the platelet count normalized after isoniazid discontinuation. We describe the immunological mechanism of thrombocytosis due to isoniazid, an uncommon cause of thrombocytopenia that physicians should be aware exists. |
format | Online Article Text |
id | pubmed-8666230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-86662302021-12-28 Isoniazid-induced Immune Thrombocytopenia Kuwabara, Gaku Tazoe, Kumiyo Imoto, Waki Yamairi, Kazushi Shibata, Wataru Oshima, Kazuhiro Yamada, Koichi Takagi, Yasuhiro Shiraishi, Satoshi Hino, Masayuki Kawaguchi, Tomoya Kakeya, Hiroshi Intern Med Case Report Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who developed thrombocytopenia during tuberculosis treatment. Platelet-associated immunoglobulin G and a drug-induced lymphocyte stimulation test for isoniazid were positive; no other causes of thrombocytopenia were identified. The patient was diagnosed with isoniazid-induced immune thrombocytopenia, and the platelet count normalized after isoniazid discontinuation. We describe the immunological mechanism of thrombocytosis due to isoniazid, an uncommon cause of thrombocytopenia that physicians should be aware exists. The Japanese Society of Internal Medicine 2021-05-29 2021-11-15 /pmc/articles/PMC8666230/ /pubmed/34053983 http://dx.doi.org/10.2169/internalmedicine.6520-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kuwabara, Gaku Tazoe, Kumiyo Imoto, Waki Yamairi, Kazushi Shibata, Wataru Oshima, Kazuhiro Yamada, Koichi Takagi, Yasuhiro Shiraishi, Satoshi Hino, Masayuki Kawaguchi, Tomoya Kakeya, Hiroshi Isoniazid-induced Immune Thrombocytopenia |
title | Isoniazid-induced Immune Thrombocytopenia |
title_full | Isoniazid-induced Immune Thrombocytopenia |
title_fullStr | Isoniazid-induced Immune Thrombocytopenia |
title_full_unstemmed | Isoniazid-induced Immune Thrombocytopenia |
title_short | Isoniazid-induced Immune Thrombocytopenia |
title_sort | isoniazid-induced immune thrombocytopenia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666230/ https://www.ncbi.nlm.nih.gov/pubmed/34053983 http://dx.doi.org/10.2169/internalmedicine.6520-20 |
work_keys_str_mv | AT kuwabaragaku isoniazidinducedimmunethrombocytopenia AT tazoekumiyo isoniazidinducedimmunethrombocytopenia AT imotowaki isoniazidinducedimmunethrombocytopenia AT yamairikazushi isoniazidinducedimmunethrombocytopenia AT shibatawataru isoniazidinducedimmunethrombocytopenia AT oshimakazuhiro isoniazidinducedimmunethrombocytopenia AT yamadakoichi isoniazidinducedimmunethrombocytopenia AT takagiyasuhiro isoniazidinducedimmunethrombocytopenia AT shiraishisatoshi isoniazidinducedimmunethrombocytopenia AT hinomasayuki isoniazidinducedimmunethrombocytopenia AT kawaguchitomoya isoniazidinducedimmunethrombocytopenia AT kakeyahiroshi isoniazidinducedimmunethrombocytopenia |